Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $13.43 in the prior trading day, Immunome Inc (NASDAQ: IMNM) closed at $13.17, down -1.94%. In other words, the price has decreased by -$1.94 from its previous closing price. On the day, 0.54 million shares were traded. IMNM stock price reached its highest trading level at $13.88 during the session, while it also had its lowest trading level at $13.1.
Ratios:
Our goal is to gain a better understanding of IMNM by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.12 and its Current Ratio is at 7.12. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Sandler on May 31, 2024, initiated with a Overweight rating and assigned the stock a target price of $27.
On April 30, 2024, JP Morgan started tracking the stock assigning a Overweight rating and target price of $24.
On April 15, 2024, Guggenheim started tracking the stock assigning a Buy rating and target price of $35.Guggenheim initiated its Buy rating on April 15, 2024, with a $35 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 19 ’24 when Rosett Max sold 14,380 shares for $16.01 per share. The transaction valued at 230,224 led to the insider holds 47,476 shares of the business.
Rosett Max bought 14,380 shares of IMNM for $230,211 on Sep 19 ’24. On Aug 16 ’24, another insider, BIENAIME JEAN JACQUES, who serves as the Director of the company, bought 7,000 shares for $13.94 each. As a result, the insider paid 97,608 and bolstered with 16,615 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IMNM now has a Market Capitalization of 790916480 and an Enterprise Value of 515335072. For the stock, the TTM Price-to-Sale (P/S) ratio is 73.36 while its Price-to-Book (P/B) ratio in mrq is 3.11. Its current Enterprise Value per Revenue stands at 47.787 whereas that against EBITDA is -7.202.
Stock Price History:
Over the past 52 weeks, IMNM has reached a high of $30.96, while it has fallen to a 52-week low of $6.93. The 50-Day Moving Average of the stock is -9.17%, while the 200-Day Moving Average is calculated to be -19.13%.
Shares Statistics:
The stock has traded on average 642.03K shares per day over the past 3-months and 789180 shares per day over the last 10 days, according to various share statistics. A total of 60.05M shares are outstanding, with a floating share count of 48.99M. Insiders hold about 18.42% of the company’s shares, while institutions hold 79.04% stake in the company. Shares short for IMNM as of 1726185600 were 12440370 with a Short Ratio of 19.38, compared to 1723680000 on 12547242. Therefore, it implies a Short% of Shares Outstanding of 12440370 and a Short% of Float of 21.92.
